Advanced search
Publication Cover
International Journal of Radiation Biology Volume 73, 1998 - Issue 5
Submit an article Journal homepage
14
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA doublestrand breaks as measured by pulsed-field gel electrophoresis

V. GREGOIRE M. BEAUDUIN M. BRUNIAUX B. DE COSTER M. OCTAVE PRIGNOT P. SCALLIET Laboratoire d’Etude du Me tabolisme Tumoral, Hospital de Jolimont, 7161 Haine-St-Paul, Belgium.
Pages 511-520 | Published online: 03 Jul 2009

  • BRYANT, P. E. and BLOCHER, D., 1982, The effects of 9-ß-Darabinofuranosyladenine on the repair of DNA strand breaks in X-irradiated Ehrlich ascites tumour cells. International Journal of Radiation Biology, 42, 385-394.
  • BRYANT, P. E., 1984, Effects of ara-A and fresh medium on chromosome damage and DNA double-strand break repair in X-irradiated stationary cells. British journal of Canor, 49 (suppl. Vl), 61-65.
  • CATAPANO, C. V., CHANDLER, K. B. and FERNANDES, D. J., 1991, Inhibition of primer RNA formation in CCRFCEM cells by fludarabine triphosphate. Cancer Research, 51, 1829-1835.
  • DANHAUSER, L., PLUNKETT, W., KEATING, M. and CABANILLAS, F. 1986, 9-ß-D-arabinofuranosyl-2-fluroadenine-5'-monophosphate pharmacokinetics in plasma and tumours cells of patients with relapsed leukemia and lymphoma. Cancer Chemotherapy and Pharmacology, 18, 145-152.
  • ELSHAIKH, M., HUNTER, N., MILAS, W., ANG, K. K. and MASON, K., 1997, Time dependent modulation of jejunal radioresponse with gemcitabine. Proceedings of the 45th Annual Meeting of the Radiation Research Society, 228.
  • FUJII, T., HUNTER, N., ELSHAIKH, M., HITTELMAN, W., PLUNKETT, W., ANG, K. and MILAS, L., 1997, Gemcitabine improves the therapeutic ratio of radiotherapy in mouse tumours after single dose irradiation. Proceedings of the 45th Annual Meeting of the Radiation Research Society, 229.
  • GANDHI, V. and PLUNKETT, W. 1989, Interaction of arabinosy1 nucleotides in K562 human leukemia cells. Biochemistry and Pharmacology, 38, 3351-3558.
  • GRÉGOIRE, V., BEAUDUIN, M., ROSIER, J-F., DE COSTER, B., BRÉNIAUX, M., OCTAVE-PRIGNOT, M. and SCALLIET, P., 1997, Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells. British journal of Cancer, 76, 1315-1321.
  • GRÉGOIRE, V., DE BAST, M., ROSIER, J. F., BEAUDUIN, M., BRUNIAUX, M., DE COSTER, B. and SCALLIET, P., 1996, Influence of deoxycytidine kinase activity in in Mm radiosensitization by fludarabine and gemcitabine. Proceedings of the American Association for Cancer Research, 37, 612.
  • GRÉGOIRE, V and HITTELMAN, W., 1997, Nucleoside analogs as radiosensitizing agents. In Nucleoside Analogs In Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 315-358.
  • GRÉGOIRE, V., HUNTER, N., BROCK, W. A., MILAS, L., PLUNKETT, W. and HITTELMAN, W. N., 1994b, Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumours after Single dose irradiation. International Journal of Radiation Oncology, Biology, Physics, 30, 363-371.
  • GRÉGOIRE, V., HUNTER, N., MILAS, L., BROCK, W. A., PLUNKETT, W. and HITTELMAN, W. N., 1994a, Potentiation of radiation-induced regrowth delay in murine tumours by fludarabine. Cancer Research, 54, 468-474.
  • GRÉGOIRE, V., RUIFROK, A. C. C., PRICE, R. E., BROCK, W. A., HITTELMAN, W. N., PLUNKETT, W. K. and ANG, K. K., 1995, Effect of intra-peritoneal fludarabine administration on rat spinal cord tolerance to fractionated irradiation. Radiotherapy and Oncology, 36, 50-55.
  • GRÉGOIRE, V., VAN, N. T., BROCK, W. A., MILAS, L., PLUNKETT, W. and HITTELMAN, W. N., 1994c, The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumours radiation response in vivo. Cancer Research, 54, 6201-6209.
  • HEINEMANN, V., HERTEL, L. W., GRINDEY, G. B. and PLUNKETT W., 1988, Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and l-ß-Darabinofuranosylcytosine. Cancer Research, 48, 4024-4031.
  • HEINEMANN, V., Xu, Y-Z., CHUEE, S., SEN, A., HERTEL, L. W., GRINDEY, G. B. and PLUNKETT, W., 1992. Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation. Cancer Research, 52, 533-539.
  • Hiss, E. A. and PRESTON R. J., 1977, The effect of cytosine arabinoside on the frequency of single strand breaks in mammalian cells following irradiation or chemical treatment. Biochimica et Biophysica Acta, 478, 1-8.
  • HITTELMAN, W. N., FUJII, T., HUNTER, N., KONISHI, H., MASON, K., GRÉGOIRE, V., PLUNKETT, W. and MILAS, L., 1996, Identification of a window of therapeutic opportunity for the combination of gemcitabine and radiation. Proceedings of the American Association for Cancer Research, 37, 290.
  • HUANG, N. J. and HITTELMAN, W. N., 1995, Transient inhibition of chromosome damage repair after ionizing radiation by gemcitabine. Proceedings of the American Association for Cancer Research, 36, 612.
  • HUANG, P., CHUEE, S. and PLUNKETT, W., 1990, Termination of DNA synthesis by 9-j3-D-arabinofuranosyl-2-fluoroadenosine: a mechanism for cytotoxicity. journal of Biological Chemistry, 265, 16617-16625.
  • HUANG P., CHUBB S., HERTEL L. W., GRINDEY G. B. and PLUNKETT W., 1991, Action of 2',2'-difluorodeoxycytidine On DNA Synthesis. Cancer Research, 51, 6110-6117.
  • HUANG, P. and WRIGHT, S., 1997, Induction of apoptosis by nucleoside analogs. In Nucleoside Analogs in Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 37-72.
  • ILIAKIS, G. and BRYANT, P. E., 1983, Effects of the nucleoside analogues a-Ara-A, b-Ara-A and b-Ara-C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture. Anticancer Research, 3, 143-150.
  • ILIAKIS, G., PANTELIAS, G., OKAYASU, R. and SEANER, R., 1989, Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD. International Journal of Radiation Oncology, Biology, Physics, 16, 1261-1265.
  • JAYANTH, R. V. and HITTELMAN, W. N., 1991, 9-ß-D-arabinofuranosyl-2-fluroadenine (F-ara-A) inhibits both the fast and slow components of chromosome repair. In Radiation Research: A Twentieth-Century Perspective, vol. 1, edited byJ. D. Chapman, W. C. Dewey and G. F. Whitmore (San Diego: Academic), pp. 411.
  • KINSELLA, T. J., MITCHELL, J. B., Russo, A., MORSTYN, G. and GLASTEIN, E., 1984, The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status and future prospects: nonhypoxic sensitizers. International Journal of Radiation Oncology. Biology. Physics, 10, 1399-1406.
  • LAWRENCE, T. S., CHANG, E. Y., HAHN, T. M., HERTEL, L. W. and SHEWACH, D. S., 1996, Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine. International Journal of Radiation Oncology, Biology, Physics, 34, 867-872.
  • LAWRENCE, T. S., CHANG, E., HAHN, T. M. and SHEWACH, D. S., 1997, Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'deoxycytidine (gemcitabine). Clinical Cancer Research, 3, 777-782.
  • MCGINN, C. J., SHEWACH, D. S. and LAWRENCE, T. S., 1996, Radiosensitizing nucleosides. Journal of the National Cancer institute, 88, 1193-1203.
  • MCLARTY, J. W. and THAMES, H. D., 1977, A parametric method for estimation of dose-modifying factors: lowdose extrapolation limit. Radiation Research, 69, 1-15.
  • MILAS L., HUNTER N., MASON K. A., MILROSS C. and PETERS L. J., 1995, Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumours radioresponse. Acta Oncolologica, 34, 409-4012.
  • MOZDARANI H. and BRYANT P. E., 1987, The effect of 9-betaD-arabinofuranosyladenine on the formation of X-ray induced chromatid aberrations in X-irradiated G2 human Cells. Mutagenesis, 2, 371-374.
  • MULLEN, J., Xu, Y. Z., LEPEK, K., PLUNKETT, W. and RICH, T., 1994, Cytotoxicity and radiosensitization by Gemcitabine in exponential human colon adenocarcinoma (clone A) cells. Proceedings of the 42nd Annual Meeting of the Radiation Research Society, Nashville, April 29-May 4, pp. 206.
  • OSTRUSZKA, L. J. and SHEWACH, D. S., 1997, Cytotoxicity and radiosensitization of gemcitabine in human glioblastoma cell lines. Proceedings of the American Association for Cancer Research, 38, 683.
  • PETERS, G. J AND ACKLAND, S. P., 1996, New antimetabolites in preclinical and clinical development. Exp. opinion in Investigation D rugs. 5, 637-679.
  • PLUNKETT, W., HUANG, P., Xu, Y-Z., HEINEMAN, V., GRUNEWALD, R. and GANDHI, V., 1995, Gemcitabine: metabolism, mechanisms of action and self-potentiation. Seminar in Oncology, 22 (suppl. 11), 3-10.
  • PLUNKETT, W. and GANDHI, V., 1997, Nucleoside analogs: cellular pharmacology, mechanisms of action and strategies for combination therapy. In Nucleoside Analogs in Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 1-36.
  • PRESTON, R. J., 1983, Radiation damage to DNA and its repair in the formation of chromosome aberrations. In KadiationInduced Chromosome Damage in Man, edited by A. R. LUl (New York: Alan R. Liss), pp. 111-125.
  • ROCKWELL, S. and GRINDEY, G. B., 1992, Effect of 2',2'difluorodeoxycytidine on the viability and radiosensitivity Of EMT6 Cells in vitro. Oncology Research, 4, 151-155.
  • ROSIER, J. F., BEAUDUIN, M., DE BAST, M., DE COSTER, B., OCTAVE, M., SCALLIBT, P. and GRÉGOIRE, V., 1997, Radiosensitization by gerneitabine (dFdC) of radiosensitive (RS) and radioresistant (RR) human head and neck squamous carcinoma (HNSC) cell lines. Proceedings of the American Association for Cancer Research, 38, 298.
  • RUIZ VAN HAPPEREN V. W. T., VEERMAN G., BOVEN E., NOORDHUIS P., VERMOKEN J. B. and PETERS G. J., 1994, Schedule dependence of sensitivity to 2',2'Difluorodeoxycytidine (gerne itab ine) in relation to accumulation and retention of its triphosphate in solid tumour Cell lines and Solid tumours. Biochemical Pharmacology, 48, 1327-1339.
  • SANDOVAL, A., CONSOLI, U. and PLUNKETT, W., 1996, Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clinical Cancer Research, 2, 1731-1741.
  • SHEWACH, D. S., HAHN, T. M., CHANG, E., HERTEL, L. W. and LAWRENCE, T. S., 1994, Metabolism of 2',2'-difluoro-2'deoxycytidine and radiation sensitization of human colon Carcinoma Cells. Cancer Research, 54, 3218-3223.
  • SHEWACH, D. S. and LAWRENCE, T. S., 1995, Radiosensitization of human tumours cells by gerneitabine in vitro. Seminar in oncology, 22 (suppl. 11), 68-71.
  • TSENG, W. C., DERSE, D., CHENG, Y. C., BROCKMAN, R. W. and BENNETT, L. L. JR., 1982, in vitro biological activity of 9-ß-D-arabinofuranosyl-2-fluoroadenosine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Molecular Pharmacology, 21, 474-477.
  • WARD, J. F., JONER, E. I. and BLAKELY, W. F., 1984, Effects of inhibitors of DNA strand break repair on HeLa cell radiosensitivity. Cancer Research, 44, 59-63.
  • WARD, J. F., 1985, Biochemistry of DNA lesions. Radiation Research, 104, S103-111.
  • WARD, J. F., 1988, DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation and reparability. Progress in Nucleic Acid Molecular Biology, 35, 95-125.
  • WEBSTER, L. K., JOSCHKO, M. A., GROVES, J., YUEN, K., BISHOP, J. F., BALL, D. L. and MILLWARD M. J., 1997, Radioenhancement by gemcitabine with accelerated fractionated radiotherapy in a human tumours xenograft. Proceedings of the American Association for Cancer Research, 38, 248.
  • WOOD, R. D., 1996, DNA repair in eukaryotes. Annual Review in Biochemistry, 65, 135-167.
  • YANG, S. W., HUANG, P., PLUNKETT, W., BECKER, F. F. and CHAN,J. Y. H., 1992, Dual mode of inhibition of purified DNA ligase I from human cells by 9-ß-D-arabinofuranoSyl-2-fluoroadenosine. Journal of Biological Chemistry, 267, 2345-2349.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.